Aligos Therapeutics, Inc. (ALGS)
5.76
-0.45
(-7.25%)
USD |
NASDAQ |
Sep 08, 16:00
6.40
+0.64
(+11.11%)
After-Hours: 07:06
Aligos Therapeutics Price to Book Value : 1.127 for Sept. 8, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 1.127 |
| September 04, 2026 | 1.215 |
| September 03, 2026 | 1.217 |
| September 02, 2026 | 1.215 |
| September 01, 2026 | 1.191 |
| August 31, 2026 | 1.146 |
| August 28, 2026 | 1.352 |
| August 27, 2026 | 1.383 |
| August 26, 2026 | 1.469 |
| August 25, 2026 | 1.461 |
| August 24, 2026 | 1.356 |
| August 21, 2026 | 1.305 |
| August 20, 2026 | 1.260 |
| August 19, 2026 | 1.348 |
| August 18, 2026 | 1.322 |
| August 17, 2026 | 1.286 |
| August 14, 2026 | 1.348 |
| August 13, 2026 | 1.324 |
| August 12, 2026 | 1.369 |
| August 11, 2026 | 1.424 |
| August 10, 2026 | 1.496 |
| August 07, 2026 | 1.094 |
| August 06, 2026 | 1.078 |
| August 05, 2026 | 0.9272 |
| August 04, 2026 | 0.9291 |
| Date | Value |
|---|---|
| August 03, 2026 | 0.8998 |
| July 31, 2026 | 0.8274 |
| July 30, 2026 | 0.845 |
| July 29, 2026 | 0.8313 |
| July 28, 2026 | 0.8313 |
| July 27, 2026 | 0.7981 |
| July 24, 2026 | 0.7981 |
| July 23, 2026 | 0.9174 |
| July 22, 2026 | 1.007 |
| July 21, 2026 | 1.064 |
| July 20, 2026 | 1.033 |
| July 17, 2026 | 1.123 |
| July 16, 2026 | 1.125 |
| July 15, 2026 | 1.129 |
| July 14, 2026 | 1.194 |
| July 13, 2026 | 1.244 |
| July 10, 2026 | 1.295 |
| July 09, 2026 | 1.324 |
| July 08, 2026 | 1.316 |
| July 07, 2026 | 1.191 |
| July 06, 2026 | 1.144 |
| July 02, 2026 | 1.094 |
| July 01, 2026 | 1.066 |
| June 30, 2026 | 1.129 |
| June 29, 2026 | 1.057 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 18.19 |
| Anika Therapeutics, Inc. | 2.051 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.715 |
Price to Book Value Related Metrics
| PS Ratio | 1.90 |
| Price | 5.76 |
| Earnings Yield | -127.0% |
| Market Cap | 35.92M |